In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Latest
Ahold Delhaize bets on value, omnichannel and AI in 2026
"Being a consistent and trusted partner for customers and stakeholders is essential."
Islandia clears way for site of Trader Joe's distribution hub
The Islandia village board approved the design for the 922,084‑square‑foot facility in July
7-Eleven restaurants unveil $5 chicken deals
Turn up the flavor with the new Lemon Pepper Glaze for a vibrant, zesty twist on menu favorites.